| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |